K
Kura Oncology, Inc. (KURA)
NMS – Real Time Price. Currency in USD
10.90
+0.54 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
10.90
+0.54 (5.21%)
At close: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
After-hours: Jun 26, 2026, 7:31 PM EDT
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Francis J. Burrows Ph.D. | Chief Scientific Officer |
| Dr. Mollie Leoni M.D. | Chief Medical Officer |
| Dr. Roger Bakale Ph.D. | Senior Vice President of Manufacturing & Supply Chain |
| Dr. Troy Edward Wilson J.D., Ph.D. | Chairman, CEO & President |
| Mr. Brian T. Powl M.B.A., M.S. | Chief Commercial Officer |
| Mr. Greg Mann | Senior Vice President of Investor Relations & Corporate Affairs |
| Mr. Samir Vattompadam M.S. | Senior Vice President of Global Program Leadership |
| Mr. Thomas Doyle | Senior Vice President of Finance & Accounting |
| Ms. Kathleen Ford | Chief Operating Officer |
| Ms. Teresa Brophy Bair Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-06-04 | S-8 | kura-20260604.htm |
| 2026-06-04 | 8-K | kura-20260604.htm |
| 2026-05-26 | DEFA14A | d124531ddefa14a.htm |
| 2026-05-12 | 8-K | kura-20260512.htm |
| 2026-05-12 | 10-Q | kura-20260331.htm |
| 2026-04-10 | DEFA14A | kura_defa_14a_2026.htm |
| 2026-04-10 | DEF 14A | kura-20260410.htm |
| 2026-04-10 | ARS | kura_ars_2025.pdf |
| 2026-03-05 | 8-K | kura-20260305.htm |
| 2026-03-05 | 10-K | kura-20251231.htm |